¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ether centrifugal sedimentation method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sedimentation technique
    ħÀü¹ý
  • sedimentation time
    ħ°­½Ã°£
  • sedimentation velocity
    ħÀü¼Óµµ, ħ°­¼Óµµ
  • Westergren sedimentation rate
    ¿þ½ºÅͱ׷»Ä§°­¼Óµµ
  • zeta sedimentation ratio
    Á¦Å¸Ä§°­ºñ
  • ascending method
    ¿Ã¸²¹ý, »ó½Â¹ý
  • aspirative irrigation method
    ÈíÀμ¼Ã´¹ý
  • auscultatory method
    ûÁø¹ý
  • acquisition method
    ȹµæ¹æ¹ý
  • activated sludge method
    Ȱ¼ºÇذ¨¸ð·¡¹ý, Ȱ¼º¿À´Ï¹ý
  • actuarial method
    º¸ÇèÅë°è¹ý
  • agar diffusion method
    ¿ì¹«È®»ê¹ý
  • alkali denaturation method
    ¾ËÄ®¸®º¯¼º¹ý
  • allochromatic method
    º¯»ö¹ý
  • alternate paired case method
    ±³´ë´ë¸³È¯ÀÚ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sedimentation level
    ħÀüÃþ
  • sedimentation rate
    ħ°­·ü
  • sedimentation reaction
    ħÀü¹ÝÀÀ
  • Westergren sedimentation rate
    ¿þ½ºÅͱ׷»Ä§°­¼Óµµ
  • zeta sedimentation ratio
    Á¦Å¸Ä§°­ºñ
  • sedimentation
    ħÀü
  • sedimentation technique
    ħÀü¹ý
  • sedimentation time
    ħÀü½Ã°£
  • sedimentation velocity
    ħÀü¼Óµµ
  • acquisition method
    ȹµæ¹æ¹ý
  • activated sludge method
    Ȱ¼ºÇذ¨¸ð·¡¹ý, Ȱ¼º¿À´Ï¹ý
  • actuarial method
    º¸ÇèÅë°è¹ý
  • agar diffusion method
    ¿ì¹«È®»ê¹ý
  • agar filtration method
    ¿ì¹«°Å¸£±â¹ý, ¿ì¹«¿©°ú¹ý
  • agar layer method
    ¿ì¹«ÁßÃþ¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Chopper method Chopper
    ¹ý
  • Clinistix method
    Ŭ¸®´Ï½ºÆ½½º(¹æ)¹ý
  • Clinitest method
    Ŭ¸®´ÏÅ×½ºÆ®(¹æ)¹ý
  • Crede method of expressing placenta
    Å©·¹µ¥ ŹݾÐÃà¹ý.
  • Halsteds method (operation)
    Ȧ½ºÅ×µå ¼ö¼ú.
  • Hegar s method =H s operation
    Çì°¡¼ö ¼ú.
  • India ink method
    ¸Ô¹°°æ°Ë¹ý
  • Indian ink method
    ¸Ô¹°µµ¸»¹ý
  • Kay-Bodansky method
    Ä«ÀÌ-º¸´Ü½ºÅ°¹ý
  • King-Armstrong method
    Å·-¾Ï½ºÆ®·Õ¹ý
  • Lod score method
    ·ÎµåÁ¡¼ö¹ý
  • Lyman s method
    ¶óÀ̸¸¹ý.
  • Maitlands culture method
    ¸¶ÀÌÆ®·£µå¹è¾ç¹ý
  • Mancini method
    ¸¸½Ã´Ï¹ý
  • Octoson scanning method
    ¿ÁÅä¼Õ ½ºÄµ¹ý (Ûö)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ether
    ÀÌÅÍ.
  • ether
    ¿¡Å׸£, ¿¡ÅÚ.
  • ether anesthesia
    ¿¡Å׸£¸¶Ãë¹ý.
  • ether bronchitis
    ¿¡Å׸£±â°üÁö¿°.
  • ether susceptibility
    ¿¡Å׸£°¨¼ö¼º (¿ÜÇǺ¸À¯¹ÙÀÌ·¯½ºÀÇ)
  • mitigated ether
    ¿ÏÈ­(èÐûú)¿¡Å׸£.
  • mitigated ether
    ¿ÏÈ­(èÐûú)¿¡Å׸£ ¡ìŬ·Î·ÎÆ÷¸§È¥ÇÕ¡í.
  • petroleum ether
    ¼®À¯¿¡Å׸£.
  • phenyl ether
    Æä´Ò¿¡Å׸£.
  • trifluoroethyl vinyl ether
    Æ®¸®Ç÷ç¿À·Î¿¡Æ¿ºñ´Ò¿¡Å׸£.
  • coefficient, sedimentation
    ħ°­Áö¼ö
  • erythrocyte sedimentation
    ÀûÇ÷±¸Ä§°­(ËøÌ´Ë´ ˧).
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ
  • erythrocyte sedimentation reaction
    ÀûÇ÷±¸Ä§°­¹ÝÀÀ.
  • erythrocyte sedimentation test
    ÀûÇ÷±¸Ä§°­½ÃÇè.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • isokinetic sedimentation
    µî¿ªÇРħÀü(ÔõÕôùÊöØîþ)
  • meniscus depletion sedimentation equilibrium
    ¸Þ´Ï½ºÄ¿½º ¼Ò½Ç ħ°­ÆòÇü(á¼ã÷öØË½øÁû¬)
  • sedimentation
    ħ°­(öØË½)
  • sedimentation coefficient
    ħ°­°è¼ö(öØË½Ìõâ¦)
  • sedimentation equilibrium
    ħ°­ÆòÇü (öØË½øÁû¬)
  • sedimentation field flow fractionation
    ħ°­Àå(öØË½íÞ) È帧ºÐȹ¹ý(ÝÂüñÛö)
  • sedimentation partition chromatography
    ħ°­ºÐ¹è(öØË½ÝÂÛÕ) Å©·Î¸¶Åä±×·¡ÇÇ
  • sedimentation potential
    ħ°­Àü¾Ð (öØË½ï³äâ)
  • sedimentation velocity
    ħ°­¼Óµµ(öØË½áÜÓø)
  • standard sedimentation coefficient
    Ç¥ÁØ Ä§°­°è¼ö(øöñÞöØË½Ìõâ¦)
  • streamer sedimentation
    È帧 ħÀü (öØîþ)
  • agar diffusion method
    ÇÑõȮ»ê¹ý(ùÎô¸üªß¤Ûö)
  • amyloclastic method
    ¾Æ¹Ð·ÎºÐÇØ¹ý(ÝÂú°Ûö)
  • amylometric method
    "¾Æ¹Ð·ÎÀ̵åÃøÁ¤¹ý(ö´ïÒÛö), ¾Æ¹Ð·ÎÀ̵å¹ý(Ûö)"
  • analytical method
    ºÐ¼®¹ý(ÝÂà°Ûö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • one probe method
    ´ÜÀÏŽÃËÀÚ¹æ½Ä
  • presaturation method
    ÀüÆ÷È­¹ý
  • pulse method
    ÆÞ½º¹ý
  • pulse spray method
    ¸Æµ¿»ìÆ÷¹ý
  • reflection method
    ¹Ý»ç¹ý
  • repetitive pulse method
    ¹Ýº¹ÆÞ½º¹ý
  • transfrontal method
    °æÀüµÎ¹æ¹ý
  • transmission method
    Åõ°ú¹ý
  • uniform insonation method
    ±ÕµîÀ½ÆÄÁ¶»ç¹ý
  • water filled method
    ¹°Ã游¹ý
  • Zebra-stripe imaging method
    ¾ó·è¸»¹«´Ì¿µ»ó¹æ¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DCF 2'-deoxycoformycin; dichlorofluorescin; direct centrifugal flotation; dopachrome conversion factor
ICF immunodeficiency-centromeric instability-facial anomalies [syndrome]; indirect centrifugal flotation...
MCFA medium-chain fatty acid; miniature centrifugal fast analyzer
RCF red cell ferritin; red cell folate; relative centrifugal field/force; ristocetin cofactor
RPHAMFCA reversed passive hemagglutination by miniature centrifugal fast analysis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CCE Countercurrent centrifugal elutriation
CCE Counterflow centrifugal elutriation
CP centrifugal pump
BEM Boundary Elements Method
CAM Confusion Assessment Method
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • activated sludge method
    Ȱ¼º ¿À´Ï¹ý
  • agar diffusion method
    ÇÑõ È®»ê¹ý, ÇÑõ³» È®»ê¹ý
    ÇÑõÀÇ °Ö ³»¿¡¼­ ħ°­¹ÝÀÀÀ» ÇàÇÏ´Â ¹æ¹ýÀ̰í 2Á¾ ÀÌ»óÀÇ Ç׿ø ¹× Ç×ü°¡ °ü¿©ÇÏ´Â ¹ÝÀÀÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ´Â °ÍÀÌ °¡´ÉÇÏ´Ù. ¹ÝÀÀ ÀÎÀÚÀÇ ¾î´À ÇÑÂÊÀ» ÇÑõ ³»¿¡ ³ì¿©µÎ°í ´Ù¸¥ ÀÎÀÚ¸¦ È®»ê½ÃŰ´Â ´Ü¼ø È®»ê¹ý°ú ÇÑõÀÇ Áß°£Ãþ°ú ¶³¾îÁ®¼­ Ç׿ø°ú Ç×ü¸¦ È®»ê½ÃŰ´Â 2Áß È®»ê¹ý, ±×¸®°í ¸é¿ª Àü±â ¿µµ¿ÀÌ ÀÖ´Ù.
  • alkaline phosphatase antialkaline phophatase method
    ¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦ Ç×¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦¹ý
  • aspirative-irrigation method
    È©ÀÎ ¼¼Ã´¹ý
  • Barber's method
    ¹Ù¾Æ¹ö ¹ý
    ¹Ì»ý¹°À» Çö¹Ì°æ¿¡¼­ ´Ü¸®ÇÏ´Â Á¶ÀÛ¹ý.
  • Barker's method
    ¹Ù¾ÆÄ¿¹ý
    Ƽ¿À½Ã¾È¿°°ú Á¦ 2Áú»ê öÀÇ È­ÇÕ¿¡ ÀÇÇÑ ºñ»ö¹ý.
  • bioassay method
    »ý¹°ÇÐÀû °ËÁ¤¹ý
  • candle jar method
    Ä­µé Àھƹý, Ä­µé ÀÚ¾Æ ¹è¾ç¹ý
  • carbol fuchsin method
    Ä«¸£º¼ Ǫũ½Å ¹ý
  • Charter's method
    Â÷ÅÍ ¹ý
    Ä©¼Ö »ç¿ë¹ýÀÇ Çϳª·Î, ¼ÖÀÌ Ä¡¾Æ¿Í Ä¡Àº¿¡ ´ëÇÏ¿© 45¡Æ·Î Ä¡°ü ÂÊÀ¸·Î ±â¿ï¾îÁö°Ô Çϸ鼭 ¼öÆòÀ» À¯Áö½ÃŰ°í ¼ÖÀÇ ¹ÝÀº Ä¡¾Æ¿¡ ±×¸®°í ¹ÝÀº Ä¡Àº¿¡ ÀÖµµ·Ï ÇÑ ´ÙÀ½, ¾ÆÁÖ ÀÛÀº ¿øÀ» ±×¸®´Â µíÇÑ Áøµ¿ ¿îµ¿À» Áָ鼭 ÇÏ´Â ¹æ¹ý. À½½Ä Â±â¿Í Ä¡°£¿¡ ¼ÖÀÌ µé¾î°¡°Ô µÇ¾î ¸¶»çÁö ¿ªÇÒµµ ÇÑ´Ù.
  • Chopper method
    Chopper ¹ý
  • column diffusion method
    ±âµÕ È®»ê ¹æ¹ý
  • combination method
    ¿¬ÇÕ¹ý
    Àη¹À̳ª Ä¡°ü º¸Ã¶ Á¦ÀÛ¿¡¼­ ¸ðÇü»ó¿¡ ³³ÇüÀ» ÀÏÂ÷·Î ¿Ï¼ºÇÏ¿© ±¸°­³»¿¡ ½ÃÀûÇÏ¿© ½Ã°øÇÏ°í ¸Å¸ôÇÏ¿© ÁÖÁ¶ÇÏ¿© ¾ò´Â °£Á¢¹ý°ú Á÷Á¢¹ýÀ» °â¿ëÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • Dehn-Clark`s method
    µ§-Ŭ¶óÅ©¹ý
  • Denis-Leche's method
    µ¥´Ï½º-·¹Ä¡¹ý
    Àü Ȳȭ¹°ÀÇ °ËÃâ¹ýÀ¸·Î, »êÀ» °¡ÇØ ºÎÆÐÇÑ ´Ü¹éÁúÀ» Á¦°ÅÇÏ°í ¿°È­ ¹Ù·ý¿¡ ÀÇÇØ ħÀü °ÇÁ¶½ÃŲ ÈÄ Äª·®ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
zeta sedimentation ratio The ratio of the zetacrit to the haematocrit, normally 0.41 to 0.54 (41 to 54%); it is a sensitive indicator of the erythrocyte sedimentation rate (ESR) and, unlike the latter, is unaffected by anaemia, which tends to elevate the ESR.
(05 Mar 2000)
anaesthetic ether General designation for many ether's.
(05 Mar 2000)
bis(chloromethyl) ether <chemical> Sym-dlchloromethyl ether. A substance that is an irritant to the eyes and respiratory tract and may be carcinogenic.
Pharmacological action: carcinogens, irritants.
Chemical name: Methane, oxybis(chloro-
(12 Dec 1998)
boldine dimethyl ether <chemistry> An alkaloid obtained from the plant Glaucium, as a bitter, white, crystalline substance.
Source: Websters Dictionary
(01 Mar 1998)
vinyl ether O(CH==CH2)2;a volatile liquid, the vapor of which produces rapid induction of general anaesthesia; prolonged administration is associated with adverse side effects on the liver and central nervous system; an obsolete agent.
Synonym: vinyl ether.
(05 Mar 2000)
guaiacol glyceryl ether <chemical> 3-(2-methoxyphenoxy)-1,2-propanediol. An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Pharmacological action: expectorants.
Chemical name: 1,2-Propanediol, 3-(2-methoxyphenoxy)-
(12 Dec 1998)
guaiacylglycerol beta-O-4-guaiacyl ether dehydrogenase <enzyme> Nad+ required; forms the corresponding ketone at the alpha carbon of the glycerol side chain
Registry number: EC 1.1.1.-
Synonym: gge dehydrogenase
(26 Jun 1999)
petroleum ether petroleum benzin
methyl-tert-butyl ether Used to dissolve gallbladder stones.
Acronym: MTBE
(05 Mar 2000)
halothane-ether azeotrope An azeotropic mixture in the proportions halothane 68 to diethyl ether 32, by volume, that combines the advantages of each anaesthetic yet is non-flammable.
Origin: G. A-priv. + zeein, to boil, + tropos, a turning
(05 Mar 2000)
xylostyptic ether Tannic acid in flexible collodion; an astringent and local haemostatic.
Synonym: haemostatic collodion, styptic colloid, xylostyptic ether.
(05 Mar 2000)
solvent ether A fairly pure form of ether (C4H10O) but not sufficiently pure for anaesthesia; used as a solvent.
(05 Mar 2000)
sulfuric ether CH3CH2OCH2CH3;a flammable, volatile organic solvent used in extraction procedures; formerly widely used as an inhalation anaesthetic; shortcomings include: irritating vapor, slow onset and prolonged recovery phase, explosion hazard.
Synonym: ethyl ether, ethyl oxide, sulfuric ether.
(05 Mar 2000)
diethyl ether CH3CH2OCH2CH3;a flammable, volatile organic solvent used in extraction procedures; formerly widely used as an inhalation anaesthetic; shortcomings include: irritating vapor, slow onset and prolonged recovery phase, explosion hazard.
Synonym: ethyl ether, ethyl oxide, sulfuric ether.
(05 Mar 2000)
dihematoporphyrin ether <chemical> The purified component of haematoporphyrin derivative, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (haematoporphyrin photoradiation) to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of photodynamic therapy in the united states.
Pharmacological action: antineoplastic agent, antiviral agents, dermatologic agents.
Chemical name: 21H,23H-Porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21H,23H-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl-
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • case method
    »ç·Ê ¿¬±¸¹ý;=CASE SYSTEM
  • critical path analysis (method)
    Å©¸®Æ¼Äà ÆÐ½º ºÐ¼®¹ý(ÇÁ·ÎÁ§Æ®ÀÇ °èȹ.°ü¸®¸¦ °úÇÐÀûÀ¸·Î ÇÏ´Â ¹æ¹ý)
  • direct method
    (¿Ü±¹¾îÀÇ)Á÷Á¢ ±³¼ö¹ý(¿Ü±¹¾î¸¸À¸·Î °¡¸£Ä¡¸ç ¹®¹ý ±³À°µµ ÇÏÁö ¾ÊÀ½)
  • discovery method
    ¹ß°ß ÇнÀ¹ý(Çлý¿¡°Ô ÀÚÁÖÀûÀÎ Áö½Ä ½Àµæ,¹®Á¦ ÇØ°áÀ» ½ÃŰ´Â ±³À°¹ý) er
  • field method
    ¾ß¿Ü ¿¬±¸¹ý !
  • graduated length method
    Á¡Â÷Àû ±æÀÌ º¯°æ¹ý(±â¼úÀÇ Çâ»ó¿¡ µû¶ó ½ºÅ°¸¦ ±ä °ÍÀ¸·Î Á¡Â÷ ¹Ù²Ù¾î °¡´Â ½ºÅ° Áöµµ¹ý)
  • method
    ¹æ¹ý;¹æ½Ä;(±ÔÄ¢¹Ù¸¥)¼ø¼­;Áú¼­
  • project method
    ±¸¾È ±³¼ö¹ý(ÇлýÀÇ µÎ³ú Ȱµ¿°ú ÀÛ¾÷À» ¿ä±¸ÇÏ´Â ½Ç¹° ±³¼ö)
  • rhythm method
    ÁÖ±â ÇÇÀÓ¹ý 6
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á